The Use of Cardiotonic Drugs in Neonates.pdf (983 kB)
The use of cardiotonic drugs in neonates
There is a distinct lack of age-appropriate cardiotonic drugs, and adult derived formulations continue to be administered, without evidence-based knowledge on their dosing, safety, efficacy, and long-term effects. Dopamine remains the most commonly studied and prescribed cardiotonic drug in the neonatal intensive care unit (NICU), but evidence of its effect on endorgan perfusion still remains. Unlike adult and pediatric critical care, there are significant gaps in our knowledge on the use of various cardiotonic drugs in various forms of circulatory failure in the NICU.
History
Publication status
- Published
File Version
- Accepted version
Journal
Clinics in PerinatologyISSN
0095-5108Publisher
ElsevierExternal DOI
Issue
2Volume
46Page range
273-290Department affiliated with
- BSMS Publications
Full text available
- Yes
Peer reviewed?
- Yes
Legacy Posted Date
2019-09-11First Open Access (FOA) Date
2020-03-30First Compliant Deposit (FCD) Date
2019-09-11Usage metrics
Categories
No categories selectedLicence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC